Dr. Karnes' primary area of research interest is cardiovascular and immune pharmacogenomics, specifically investigating the utility of genetic polymorphisms to predict adverse drug reactions. He employs a translational approach to investigate pharmacogenomic associations using observational studies, functional genomics techniques, and eventually prospective clinical trials.
Dr. Karnes serves as the Director of Scientific Programs for the University of Arizona-Banner All of Us Research program. He has received support for his research from the American Heart Association, the Flinn Foundation, the American College of Clinical Pharmacy, and the NIH, including R01 and K01 grants from the National Heart, Lung, and Blood Institute. Visit Dr. Karnes' faculty and laboratory websites for more information (www.pharmacy.arizona.edu/directory/jason-h-karnes-pharmd-phd-bcps and https://karneslab.org/).